Cineverse Reports Steep Losses, Negative Cash Flow, and Significant Dilution Risk for FY2026
CNVS sits 71% above its 52-week low of $1.77.
Summary
Cineverse Corp. reported a significant net loss and negative cash flow for fiscal year 2026, alongside substantial dilutive financing activities including a public offering, convertible notes, and an expanded ATM program, raising serious concerns about its financial stability and future shareholder value.
Key Events · Financing and Capital Events · CNVS
-
Significant Financial Deterioration
Cineverse reported a net loss of $(9.2) million and negative cash flow from operations of $(26.5) million for fiscal year 2026, a sharp decline from profitability in the prior year. Adjusted EBITDA also turned negative at $(3.4) million.
-
Heavy Dilutive Financing Activities
The company raised capital through a public offering of 1.725 million shares for $3.1 million net proceeds, issued $13.0 million in 9% convertible notes (convertible into 6.5 million shares), and sold 397,000 shares for $1.0 million under its ATM program. An additional $5.8 million was generated from warrant exercises.
-
Increased Dilution Risk
Cineverse explicitly warned of 'significant dilution' due to 275 million authorized shares with less than 10% currently outstanding, alongside outstanding convertible notes and warrants, and an expanded $30 million ATM program (increased on June 8, 2026).
-
Liquidity and Debt Concerns
The company ended the fiscal year with only $3.4 million in cash and negative working capital of $(12.2) million. It had $9.4 million outstanding on its line of credit and received a covenant holiday through Q4 FY2026, indicating prior financial stress.
Analysis · CNVS · Trade & Services
This annual report reveals a company facing severe financial challenges, marked by a substantial net loss and negative cash flow from operations. Cineverse has relied heavily on dilutive financing activities, including a public offering, convertible notes, and an expanded at-the-market (ATM) program, to maintain liquidity. The explicit warning about potential "significant dilution" to existing shareholders, coupled with a large number of authorized but unissued shares and convertible securities, signals a high risk to shareholder value. Despite recent acquisitions adding revenue, they have not offset the overall financial deterioration, and one acquisition even stemmed from a forced sale, indicating underlying distress. The company's low cash balance and negative working capital underscore ongoing liquidity concerns.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 41.8% of the 328 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CNVS was trading at $3.03 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $57.1M. The 52-week trading range was $1.77 to $7.39. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.